Develop effective malaria vaccines that induce long-lasting protection using mRNA technology.
2022–2030
Professor James Beeson and his team are leading next-generation vaccine development for malaria by designing and engineering mRNA vaccines to contain specific proteins of malaria to generate antibodies that can provide highly protective immunity against malaria. The project aims to develop vaccines for Plasmodium falciparum and Plasmodium vivax, which are the two major causes of malaria. Additionally, the is identifying approaches that can generate a long-lasting protective immune response against malaria.
An effective vaccine will alleviate the disease burden in communities globally, especially in low-middle-income settings where the malaria is the highest and where access to resources and health care can be severely constrained.
Professor James Beeson
Contact Professor James Beeson for more information about this project.
Learn about the Burnet Vaccine Initiative
Find out moreFunding
Partners
- mRNA Victoria (Victorian Department of Jobs, Skills, Industry, and Regions)
Partners +
Collaborators
- Monash Institute of Pharmaceutical Sciences (led by Prof Colin Pouton)
Project
Team
Meet the project team. Together, we are translating research into better health, for all.